National Institutes of Health to Grant Exclusive Patent License for Prostatic Diseases Therapies

Summary

The National Institutes of Health is considering granting an exclusive patent license to practice certain inventions related to therapies for prostatic diseases, including patents and patent applications owned by BN ImmunoTherapeutics.